EE03420B1 - Farmatseutiline kompositsioon maania ja bipolaarse häire raviks - Google Patents

Farmatseutiline kompositsioon maania ja bipolaarse häire raviks

Info

Publication number
EE03420B1
EE03420B1 EE9700302A EE9700302A EE03420B1 EE 03420 B1 EE03420 B1 EE 03420B1 EE 9700302 A EE9700302 A EE 9700302A EE 9700302 A EE9700302 A EE 9700302A EE 03420 B1 EE03420 B1 EE 03420B1
Authority
EE
Estonia
Prior art keywords
bipolar disorder
pharmaceutical composition
treating mania
mania
treatment
Prior art date
Application number
EE9700302A
Other languages
English (en)
Estonian (et)
Other versions
EE9700302A (et
Inventor
Chandra Pande Atul
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE9700302A publication Critical patent/EE9700302A/xx
Publication of EE03420B1 publication Critical patent/EE03420B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EE9700302A 1995-05-15 1996-04-26 Farmatseutiline kompositsioon maania ja bipolaarse häire raviks EE03420B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/440,570 US5510381A (en) 1995-05-15 1995-05-15 Method of treatment of mania and bipolar disorder
PCT/US1996/005898 WO1996036328A1 (en) 1995-05-15 1996-04-26 A method of treatment of mania and bipolar disorder

Publications (2)

Publication Number Publication Date
EE9700302A EE9700302A (et) 1998-06-15
EE03420B1 true EE03420B1 (et) 2001-06-15

Family

ID=23749281

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700302A EE03420B1 (et) 1995-05-15 1996-04-26 Farmatseutiline kompositsioon maania ja bipolaarse häire raviks

Country Status (19)

Country Link
US (1) US5510381A (cs)
EP (1) EP0825857B1 (cs)
JP (1) JPH11505244A (cs)
AT (1) ATE218857T1 (cs)
AU (1) AU702435B2 (cs)
CA (1) CA2215923C (cs)
CZ (1) CZ288072B6 (cs)
DE (1) DE69621799T2 (cs)
DK (1) DK0825857T3 (cs)
EE (1) EE03420B1 (cs)
ES (1) ES2177783T3 (cs)
GE (1) GEP20002014B (cs)
HU (1) HUP9802087A3 (cs)
NO (1) NO315967B1 (cs)
NZ (1) NZ307366A (cs)
PT (1) PT825857E (cs)
SK (1) SK281982B6 (cs)
WO (1) WO1996036328A1 (cs)
ZA (1) ZA963826B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
US6294690B1 (en) 1997-10-07 2001-09-25 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
AU755800B2 (en) * 1997-10-27 2002-12-19 Warner-Lambert Company Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
EP1077692B1 (en) 1998-05-15 2004-07-28 Warner-Lambert Company LLC Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
EP1077691B1 (en) * 1998-05-15 2008-09-10 Warner-Lambert Company LLC Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
KR20010043831A (ko) 1998-05-26 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 칼슘 채널의 알파2델타 서브유닛에 대한 친화력이 있는구조적으로 한정된 아미노산 화합물
JP2002520277A (ja) 1998-07-09 2002-07-09 ワーナー−ランバート・カンパニー 不眠症を治療する方法
EP1121114B1 (en) * 1998-10-16 2007-01-10 Warner-Lambert Company Llc Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders
AU4673300A (en) 1999-06-02 2000-12-18 Warner-Lambert Company Amino heterocycles useful as pharmaceutical agents
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
CA2411787C (en) * 2000-06-16 2007-03-20 Teva Pharmaceuticals Industries Ltd. Stable gabapentin having ph within a controlled range
SK17922002A3 (sk) * 2000-06-26 2003-11-04 Warner-Lambert Company Obdoby gabapentínu na liečenie porúch spánku
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
WO2015144825A1 (en) 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin
US11670410B1 (en) * 2022-04-13 2023-06-06 Green Sky Creations LLC Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
US4355044A (en) * 1980-12-19 1982-10-19 Bernardo Heller D-Phenylalanine treatment
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
PT825857E (pt) 2002-11-29
DE69621799D1 (de) 2002-07-18
NO975234D0 (no) 1997-11-14
CZ288072B6 (cs) 2001-04-11
MX9707269A (es) 1997-11-29
DK0825857T3 (da) 2002-09-30
SK152897A3 (en) 1999-05-07
WO1996036328A1 (en) 1996-11-21
EE9700302A (et) 1998-06-15
NO315967B1 (no) 2003-11-24
DE69621799T2 (de) 2003-01-02
HUP9802087A2 (hu) 1998-12-28
ZA963826B (en) 1996-11-21
CA2215923A1 (en) 1996-11-21
GEP20002014B (en) 2000-04-10
NO975234L (no) 1997-11-14
AU702435B2 (en) 1999-02-18
HUP9802087A3 (en) 1999-08-30
ATE218857T1 (de) 2002-06-15
CZ355897A3 (cs) 1998-02-18
JPH11505244A (ja) 1999-05-18
SK281982B6 (sk) 2001-09-11
ES2177783T3 (es) 2002-12-16
NZ307366A (en) 1999-10-28
US5510381A (en) 1996-04-23
CA2215923C (en) 2001-10-09
EP0825857A1 (en) 1998-03-04
EP0825857B1 (en) 2002-06-12
AU5668996A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
BR9708632A (pt) Composto calcilìticos
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE59608698D1 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE69626987D1 (de) Pharmaceutische komposition
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
BR9811643A (pt) Suplementação quìmica de osso
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DE69901805D1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
BR9713514A (pt) Novo uso de creatina
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
NO984197D0 (no) Fremgangsmåte for behandling av autisme
BR9701455A (pt) Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
NZ328198A (en) a pharmaceutical composition containing hydroxyzine and a serotonin uptake inhibitor
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
ES2085657T3 (es) Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080426